There is currently no text in this page. You can search for this page title in other pages, or search the related logs, but you do not have permission to create this page.
Category:CS1 maint: Explicit use of et al.
From Self-sufficiency
Pages in category "CS1 maint: Explicit use of et al."
The following 200 pages are in this category, out of 1,030 total.
(previous page) (next page)I
L
- Lactotripeptides
- Ladostigil
- Lamivudine
- Latrepirdine
- Left ventricular hypertrophy
- Leukemia inhibitory factor
- Leukotriene B4 receptor
- Leukotriene B4 receptor 2
- LGR4
- LGR5
- LGR6
- Libin Cardiovascular Institute of Alberta
- Lidocaine
- LiPE
- Lipoprotein lipase deficiency
- Lipoprotein(a)
- List of benzodiazepines
- List of cutaneous conditions
- List of drugs affected by grapefruit
- List of plants used as medicine
- List of vegetable oils
- Lists of former Guantanamo Bay detainees alleged to have returned to terrorism
- Loa loa filariasis
- Loeys–Dietz syndrome
- Long-term effects of benzodiazepines
- Lopinavir
- Lorazepam
- Low back pain
- Loxapine
- LPAR1
- LPAR2
- LPAR3
- LPAR4
- LPAR5
- LPAR6
- LPHN2
- LPHN3
- Luteinizing hormone/choriogonadotropin receptor
- Lymphangioma
M
- Malachite green
- Manganese
- Manual therapy
- Margarine
- Martial arts therapy
- MAS1
- MAS1L
- Mastitis
- MDMA
- Medical ultrasonography
- Medically unexplained physical symptoms
- Melanin-concentrating hormone receptor 1
- Melanin-concentrating hormone receptor 2
- Melanocortin 1 receptor
- Melanocortin 3 receptor
- Melanocortin 4 receptor
- Melanocortin 5 receptor
- Melatonin
- Melatonin receptor 1A
- Melatonin receptor 1B
- Membranous glomerulonephritis
- Meningitis
- Mercury (element)
- Mesocarb
- Mesoporous material
- Metabotropic glutamate receptor 1
- Metabotropic glutamate receptor 2
- Metabotropic glutamate receptor 3
- Metabotropic glutamate receptor 4
- Metabotropic glutamate receptor 5
- Metabotropic glutamate receptor 6
- Metabotropic glutamate receptor 7
- Metabotropic glutamate receptor 8
- Metallacrown
- Metapramine
- Metformin
- Methadone
- Methoxychlor
- Methylene blue
- Mephedrone
- Metronidazole
- Microbiology
- Minocycline
- Mirtazapine
- Morphine
- Motilin receptor
- Moxonidine
- MRGPRD
- MRGPRE
- MRGPRF
- MRGPRX1
- MRGPRX2
- MRGPRX3
- MRGPRX4
- Multicenter Automatic Defibrillator Implantation Trial
- Muscarinic acetylcholine receptor M1
- Muscarinic acetylcholine receptor M2
- Muscarinic acetylcholine receptor M3
- Muscarinic acetylcholine receptor M4
- Muscarinic acetylcholine receptor M5
- Mycophenolic acid
- Myocardial infarction
- Myxoma
N
- Necrotizing fasciitis
- Nelfinavir
- Neoplasm
- Neuralgia
- Neurokinin B
- Neuromedin B receptor
- Neuromedin U receptor 1
- Neuromedin U receptor 2
- Neuropeptide FF receptor 1
- Neuropeptide FF receptor 2
- Neuropeptide S receptor
- Neuropeptide Y receptor Y1
- Neuropeptide Y receptor Y2
- Neuropeptide Y receptor Y5
- Neuropeptides B/W receptor 1
- Neuropeptides B/W receptor 2
- Neurotensin receptor 1
- Neurotensin receptor 2
- Neurotransmitter
- Niacin receptor 2
- Niaprazine
- Nifedipine
- Nimodipine
- Nitric oxide
- Nitrofurantoin
- Nitrous oxide
- Nociceptin receptor
- Non-24-hour sleep-wake syndrome
- Nosocomial infection
- Number needed to treat
O
- Ochratoxin A
- Ocular dominance
- Oleamide
- Oleoyl-estrone
- Omega-3 fatty acid
- OPN1LW
- OPN1MW
- OPN1SW
- OPN5
- Opsin
- OR10A3
- OR10A4
- OR10A5
- OR10A7
- OR10AD1
- OR10C1
- OR10G3
- OR10H1
- OR10H2
- OR10H3
- OR10H4
- OR10J1
- OR10J3
- OR10K2
- OR10P1
- OR10R2
- OR10S1
- OR10T2
- OR10V1
- OR10W1
- OR10X1
- OR10Z1
- OR11A1
- OR11G2
- OR12D2
- OR12D3
- OR13A1
- OR13C2
- OR13C3
- OR13C4
- OR13C5
- OR13C8
- OR13F1
- OR13G1
- OR13H1
- OR13J1
- OR1A1
- OR1A2
- OR1B1
- OR1D2
- OR1D4
- OR1D5
- OR1E1
- OR1E2